Clinical Trials Browser

Recurrence × carfilzomib × Other hematologic neoplasm × Clear all

NCT02512926 2025-10-15

POE14-01

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Recurrence

NCT02145403 2022-01-03

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Phase 1/2 Completed

53 enrolled 17 charts

LymphoidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Leukemia, Lymphoma, Multiple Myeloma, Recurrence, Hematologic Neoplasms